Free Trial

Teladoc Health (NYSE:TDOC) Trading Up 9.6% on Analyst Upgrade

Teladoc Health logo with Medical background

Key Points

  • Shares of Teladoc Health surged 9.6% following an upgrade from Evercore ISI, raising the price target from $8.00 to $9.00, with the stock last trading at $9.17.
  • The company recently reported earnings of ($0.19) per share, outperforming expectations, though revenue declined 1.6% year-over-year to $631.90 million.
  • Institutional investors hold 76.82% of Teladoc Health's stock, with significant increases in positions from several funds, including a 102.6% rise from Golden State Wealth Management LLC.
  • MarketBeat previews top five stocks to own in November.

Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) rose 9.6% during trading on Wednesday after Evercore ISI raised their price target on the stock from $8.00 to $9.00. Evercore ISI currently has an in-line rating on the stock. Teladoc Health traded as high as $9.02 and last traded at $9.17. Approximately 2,618,047 shares traded hands during mid-day trading, a decline of 62% from the average daily volume of 6,813,598 shares. The stock had previously closed at $8.37.

TDOC has been the subject of a number of other reports. Mizuho assumed coverage on Teladoc Health in a report on Friday, July 25th. They set a "neutral" rating and a $10.00 price target for the company. Weiss Ratings restated a "sell (d-)" rating on shares of Teladoc Health in a report on Saturday, September 27th. Six research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $9.86.

Get Our Latest Analysis on Teladoc Health

Institutional Investors Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Golden State Wealth Management LLC raised its position in shares of Teladoc Health by 102.6% during the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after acquiring an additional 1,690 shares during the last quarter. National Bank of Canada FI increased its position in Teladoc Health by 79.4% in the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock worth $28,000 after purchasing an additional 1,581 shares during the period. SVB Wealth LLC bought a new stake in Teladoc Health during the 1st quarter worth about $37,000. BI Asset Management Fondsmaeglerselskab A S acquired a new position in Teladoc Health during the 1st quarter valued at about $50,000. Finally, Caitong International Asset Management Co. Ltd boosted its stake in shares of Teladoc Health by 8,192.0% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 8,292 shares of the health services provider's stock valued at $72,000 after purchasing an additional 8,192 shares during the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Stock Up 8.5%

The firm's 50 day moving average price is $7.68 and its 200-day moving average price is $7.60. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70. The company has a market cap of $1.60 billion, a P/E ratio of -7.69 and a beta of 1.90.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The business had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. During the same period in the prior year, the business posted ($0.38) earnings per share. Teladoc Health's revenue was down 1.6% compared to the same quarter last year. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. As a group, equities research analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current year.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Teladoc Health Right Now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.